Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1985-11-26
1988-01-26
Jiles, Henry R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514306, 540593, 546138, 546321, C07D47106, A61K 3155, A61K 31455
Patent
active
047217081
ABSTRACT:
Novel N-substituted tetrahydropyridine compounds are disclosed. The compounds have the property of inhibiting calcium induced contraction of smooth muscle and are adaptable to being employed in the chemotherapeutic treatment of cardiovascular diseases.
REFERENCES:
patent: 3883543 (1975-05-01), Bossert
patent: 3905970 (1975-09-01), Bossert et al.
patent: 3923818 (1975-12-01), Bossert et al.
patent: 4044141 (1977-08-01), Bossert et al.
patent: 4237137 (1986-12-01), Tacke et al.
patent: 4285955 (1981-08-01), Wehinger et al.
Weller, D. D. et al., J. Org. Chem. (1983), 48, pp. 3061-3067.
Goldmann, S., Angew. Chem. Int. Ed. Engl., 20 (1981), pp. 779-780.
Hartman George D.
Phillips Brian T.
Bjorkman Dale A.
Jiles Henry R.
Merck & Co. , Inc.
Robertson Alice O.
Sudol Michael C.
LandOfFree
Cyclized N-substituted-tetrahydropyridine compounds and cardiova does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cyclized N-substituted-tetrahydropyridine compounds and cardiova, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclized N-substituted-tetrahydropyridine compounds and cardiova will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1468126